Caring for Patients with Advanced Stage Cancer at the Time of COVID-19

Abstract

This letter to the editor alerts oncologists to the importance of accurately defining benefit-risk ratio during the COVID-19 pandemic for patients with advanced-stage cancer treated with chemotherapy after failure of first-line and second-line therapy.